Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Ente Ospedaliero Cantonale

ClinicalTrials.gov lists Ente Ospedaliero Cantonale as lead sponsor of 15 trials, counting the companies grouped under it.

CH Manufacturer
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 3 Related companies not grouped here Related companies not grouped here 1 Disease areas Disease areas 96 Journals published in Journals published in 61 US granted patents US granted patents 1 Manufacturing and distribution sites Manufacturing and distribution sites 2 Organization relationships Organization relationships 16 Latest dated events Latest dated events 52 Companies grouped under this page Companies grouped under this page 3 Related companies not grouped here Related companies not grouped here 1 Disease areas Disease areas 96 Journals published in Journals published in 61 US granted patents US granted patents 1 Manufacturing and distribution sites Manufacturing and distribution sites 2 Organization relationships Organization relationships 16 Latest dated events Latest dated events 52

Rows recorded per section (log scale)

1 more section with rows · 15 sections measured, none recorded

This page covers Ente Ospedaliero Cantonale and 3 companies grouped under it: 15 lead-sponsored trials (0 its own, 15 in the grouped companies) and 4 legal-entity registrations (1 its own, 3 in the grouped companies).

Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.

Get the Ente Ospedaliero Cantonale report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (3)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
Ospedale regionale di Lugano 8 1
Ospedale Regionale di Locarno 5 1
Ospedale Regionale di Mendrisio 2 1

Disease areas (96)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Prostatic Neoplasms 6
Lung Neoplasms 4
Lymphoma 4
COVID-19 3
Head and Neck Neoplasms 3

Showing 5 of 96 disease areas.

Start your 14-day trial Email me the first 50 disease areas as a PDF

Journals published in (61)

Shown in this order: most published in first.

Journals published in
Journal Publications
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 7
BMC nephrology 4
Acta neurochirurgica 3
BMJ open 3
Stroke 3

Showing 5 of 61 journals.

Start your 14-day trial Email me the first 50 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
1 0 2017-05-09

Manufacturing and distribution sites (2)

Shown in this order: severity rank then name.

Manufacturing and distribution sites
Facility Location Regulators Member organization
Ente Ospedaliero Cantonale (EOC) Bellinzona, CH EMA
Ente Ospedaliero Cantonale (EOC) Lugano, CH EMA

Organization relationships (16)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Ente Ospedaliero Cantonale, Bellinzona Co sponsors trial with 3
Repubblica e Cantone Ticino Co sponsors trial with 2
University Children’s Hospital Basel Co sponsors trial with 1
University Children's Hospital Zurich Co sponsors trial with 1
University of Bologna Co sponsors trial with 1

Showing 5 of 16 relationships.

Start your 14-day trial Email me all 16 relationships as a PDF

Latest dated events (52)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-06-19 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-06 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-01-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-04-28 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 52 events.

Start your 14-day trial Email me the first 50 events as a PDF

Biomarkers this organization publishes on (393)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
TP53 14
ERBB2 12
EGFR 11
BRCA1 10
AR 9

Showing 5 of 393 biomarkers.

Start your 14-day trial Email me the first 50 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.